Menlo Care Landmark midline catheter adverse events will be evaluated in upcoming study.
This article was originally published in The Gray Sheet
Executive Summary
MENLO CARE LANDMARK MIDLINE CATHETER: COMPARATIVE ADVERSE EVENTS STUDY will be conducted in 1996, the company says in a Jan. 12 "device bulletin" sent to 1,500 physicians. The goal of the study is to ascertain the cause of a number of adverse events reported to the company for the Landmark catheters. Menlo Care notes that testing to date "has not indicated any sensitivity or allergy to the device material," but the firm is working with FDA to "to try to understand the nature of the events and how to prevent them."